YPL-001

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameYPL-001
Drug Alias NameYPL-001
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesYungjin Pharmaceutical
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYungjin Pharm Co Ltd
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic Obstructive

Other Information

ATC CodeN/A
Related LinksN/A